BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 12644265)

  • 21. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.
    Wang Y; Ye J; Ganapathy V; Longo N
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2356-60. PubMed ID: 10051646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
    Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
    Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood-brain barrier controls carnitine level in the brain: a study on a model system with RBE4 cells.
    Mroczkowska JE; Roux FS; Naleçz MJ; Naleçz KA
    Biochem Biophys Res Commun; 2000 Jan; 267(1):433-7. PubMed ID: 10623637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of [(3)H]MPP(+) transport by phosphorylation/dephosphorylation pathways in RBE4 cells: role of ecto-alkaline phosphatase.
    Calhau C; Martel F; Soares-da-Silva P; Hipólito-Reis C; Azevedo I
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):349-56. PubMed ID: 12012020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biopharmaceutical studies on molecular mechanisms of membrane transport].
    Tsuji A
    Yakugaku Zasshi; 2002 Dec; 122(12):1037-58. PubMed ID: 12510384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive rats.
    Salsoso R; Guzmán-Gutiérrez E; Arroyo P; Salomón C; Zambrano S; Ruiz-Armenta MV; Blanca AJ; Pardo F; Leiva A; Mate A; Sobrevia L; Vázquez CM
    PLoS One; 2014; 9(2):e90339. PubMed ID: 24587332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2.
    Lahjouji K; Elimrani I; Lafond J; Leduc L; Qureshi IA; Mitchell GA
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C263-9. PubMed ID: 15238359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2.
    Sugiura T; Kato Y; Kubo Y; Tsuji A
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):375-83. PubMed ID: 17072090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-Carnitine transport in mouse renal and intestinal brush-border and basolateral membrane vesicles.
    Lahjouji K; Malo C; Mitchell GA; Qureshi IA
    Biochim Biophys Acta; 2002 Jan; 1558(1):82-93. PubMed ID: 11750267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency.
    Amat di San Filippo C; Wang Y; Longo N
    J Biol Chem; 2003 Nov; 278(48):47776-84. PubMed ID: 14506273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saturable distribution of tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport.
    Sung JH; Yu KH; Park JS; Tsuruo T; Kim DD; Shim CK; Chung SJ
    Drug Metab Dispos; 2005 Mar; 33(3):440-8. PubMed ID: 15547049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of L-carnitine in human corneal and conjunctival epithelial cells.
    Xu S; Flanagan JL; Simmons PA; Vehige J; Willcox MD; Garrett Q
    Mol Vis; 2010 Sep; 16():1823-31. PubMed ID: 21045919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2.
    Inano A; Sai Y; Nikaido H; Hasimoto N; Asano M; Tsuji A; Tamai I
    Biopharm Drug Dispos; 2003 Nov; 24(8):357-65. PubMed ID: 14595704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters.
    Martel F; Gründemann D; Calhau C; Schömig E
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):40-9. PubMed ID: 11191835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+).
    Srinivas SR; Prasad PD; Umapathy NS; Ganapathy V; Shekhawat PS
    Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1046-53. PubMed ID: 17855766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
    Ohashi R; Tamai I; Yabuuchi H; Nezu JI; Oku A; Sai Y; Shimane M; Tsuji A
    J Pharmacol Exp Ther; 1999 Nov; 291(2):778-84. PubMed ID: 10525100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5).
    Visentin M; Gai Z; Torozi A; Hiller C; Kullak-Ublick GA
    Drug Metab Dispos; 2017 Dec; 45(12):1240-1244. PubMed ID: 28986476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate.
    Grigat S; Fork C; Bach M; Golz S; Geerts A; Schömig E; Gründemann D
    Drug Metab Dispos; 2009 Feb; 37(2):330-7. PubMed ID: 18981167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and functional expression of a mouse liver organic cation transporter.
    Green RM; Lo K; Sterritt C; Beier DR
    Hepatology; 1999 May; 29(5):1556-62. PubMed ID: 10216142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-carnitine transport in kidney of normotensive, Wistar-Kyoto rats: effect of chronic L-carnitine administration.
    Gómez-Amores L; Mate A; Vázquez CM
    Pharm Res; 2003 Aug; 20(8):1133-40. PubMed ID: 12948009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.